<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Photodynamic therapy (<z:chebi fb="7" ids="53228">PDT</z:chebi>) is a minimally invasive and promising new modality to combat <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Upon illumination and in the presence of oxygen, the tissue-localized nontoxic sensitizer generates cytotoxic reactive oxygen species, and as a result, the selective destruction of a targeted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> may be achieved </plain></SENT>
<SENT sid="2" pm="."><plain>The major advantages of <z:chebi fb="7" ids="53228">PDT</z:chebi> compared to traditional standard of care for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> treatment are higher selectivity and lower toxicity </plain></SENT>
<SENT sid="3" pm="."><plain>The high degree of selectivity offered by this modality has been applied to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis by fluorescence </plain></SENT>
<SENT sid="4" pm="."><plain>PURPOSE: This article is a review the clinical effectiveness of <z:chebi fb="7" ids="53228">PDT</z:chebi> in the treatment of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and the following <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>: esophageal, gastric, biliary tract, pancreatic, and colon </plain></SENT>
<SENT sid="5" pm="."><plain>This review highlights the clinical responses to <z:chebi fb="7" ids="53228">PDT</z:chebi> and discusses the possibility of enhancing the efficacy of treatment by combination with targeted therapy </plain></SENT>
</text></document>